Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies

BACKGROUND: If symptomatic in infants, the autosomal recessive disease lysosomal acid lipase deficiency (LAL-D; sometimes called Wolman disease or LAL-D/Wolman phenotype) is characterized by complete loss of LAL enzyme activity. This very rare, rapidly progressive form of LAL-D results in severe man...

Descripción completa

Detalles Bibliográficos
Autores principales: Vijay, Suresh, Brassier, Anais, Ghosh, Arunabha, Fecarotta, Simona, Abel, Florian, Marulkar, Sachin, Jones, Simon A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789691/
https://www.ncbi.nlm.nih.gov/pubmed/33407676
http://dx.doi.org/10.1186/s13023-020-01577-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789691/
https://www.ncbi.nlm.nih.gov/pubmed/33407676
http://dx.doi.org/10.1186/s13023-020-01577-4

Ejemplares similares